New Key Statistics Module, Z-Score and F-Score
SZSE:300149 Key Ratios
Market Cap ¥ M | 2,244.00 |
Enterprise Value ¥ M | 2,521.46 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 1.56 |
Price/Sales | 2.00 |
Price/Free Cash Flow | 31.85 |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) ¥ M | 1,104.00 |
EPS (TTM) ¥ | -1.81 |
Beneish M-Score | -5.16 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -218.20 |
EV-to-EBIT | -2.81 |
EV-to-EBITDA | -2.81 |
PEG | -- |
Shares Outstanding M | 499.78 |
Net Margin (%) | -81.94 |
Operating Margin % | -5.36 |
Pre-tax Margin (%) | -83.92 |
Quick Ratio | 1.70 |
Current Ratio | 1.76 |
ROA % (ttm) | -29.85 |
ROE % (ttm) | -45.67 |
ROIC % (ttm) | -2.32 |
Dividend Yield % | -- |
Altman Z-Score | 0.57 |
SZSE:300149 Number of Guru Trades
SZSE:300149 Volume of Guru Trades
Gurus Latest Trades with SZSE:300149
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:300149 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Chempartner Pharmatech Co Ltd Insider Transactions
No Available Data